Nephrocare Health Services Limited (NSE:NEPHROPLUS)
India · Delayed Price · Currency is INR 648.95
-10.80 (-1.64%)
At close: Oct 1, 2026
NSE:NEPHROPLUS Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 65,116 | 50,858 | - | - | - | - | |
Market Cap Growth | - | - | - | - | - | - |
Enterprise Value | 61,658 | 51,497 | - | - | - | - |
Last Close Price | 648.95 | 506.85 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 75.19 | 66.19 | - | - | - | - |
Forward PE | 37.81 | 30.31 | - | - | - | - |
PS Ratio | 6.18 | 5.09 | - | - | - | - |
PB Ratio | 5.83 | 4.56 | - | - | - | - |
P/TBV Ratio | 6.54 | 5.11 | - | - | - | - |
P/FCF Ratio | 57.30 | 44.75 | - | - | - | - |
P/OCF Ratio | 28.00 | 21.87 | - | - | - | - |
PEG Ratio | 0.85 | 0.60 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 5.86 | 5.16 | - | - | - | - |
EV/EBITDA Ratio | 26.16 | 24.06 | - | - | - | - |
EV/EBIT Ratio | 42.97 | 37.09 | - | - | - | - |
EV/FCF Ratio | 54.26 | 45.32 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.44 | 0.65 | 0.55 | 0.29 |
Debt / EBITDA Ratio | 0.33 | 0.35 | 1.54 | 2.63 | 4.43 | 5.90 |
Debt / FCF Ratio | - | 0.70 | 7.25 | - | - | - |
Net Debt / Equity Ratio | -0.31 | -0.31 | 0.12 | 0.46 | 0.38 | -0.02 |
Net Debt / EBITDA Ratio | -1.51 | -1.62 | 0.44 | 2.01 | 3.52 | -0.49 |
Net Debt / FCF Ratio | - | -3.04 | 1.95 | -37.40 | -2.45 | 0.27 |
Asset Turnover | - | 0.81 | 0.84 | 0.77 | 0.71 | 0.64 |
Inventory Turnover | - | 20.77 | 18.60 | 14.68 | 15.91 | 12.38 |
Quick Ratio | - | 2.48 | 1.60 | 1.16 | 1.29 | 2.71 |
Current Ratio | - | 2.80 | 1.92 | 1.61 | 1.86 | 3.01 |
Return on Equity (ROE) | - | 9.04% | 13.45% | 8.76% | -2.94% | -6.64% |
Return on Assets (ROA) | - | 7.03% | 6.63% | 4.05% | 0.17% | -2.35% |
Return on Invested Capital (ROIC) | 15.08% | 15.37% | 11.68% | 8.36% | 0.36% | -5.10% |
Return on Capital Employed (ROCE) | - | 11.90% | 13.40% | 8.50% | 0.30% | -3.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.31% | 1.51% | - | - | - | - |
FCF Yield | 1.75% | 2.23% | - | - | - | - |
Buyback Yield / Dilution | -17.70% | -13.22% | -4.81% | -3.72% | -829.32% | 64.32% |